Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance (original) (raw)
CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results
Marta Coscia
Leukemia Research, 2019
View PDFchevron_right
Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia
Eric Everett
American Journal of Hematology, 1992
View PDFchevron_right
Quantification of CD20 mRNA and protein levels in chronic lymphocytic leukemia suggests a post-transcriptional defect
Adnan Mansoor
Leukemia Research, 2010
View PDFchevron_right
Analysis of CD200 expression in patients with Chronic-B Lymphocytic Leukemia and other chronic- B lymphoproliferative malignancies: the clinical and laboratory context
clívia Galindo
2015
View PDFchevron_right
CD20 and CD5 Expression in B-Chronic Lymphocytic Leukemia
Pablo Bertin
Annals of The New York Academy of Sciences, 1992
View PDFchevron_right
CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia
carmen mannucci
Cancers, 2021
View PDFchevron_right
S.42. Potential Role for Serum Soluble CD200 in Human Chronic Lymphocytic Leukemia
Reg Gorczynski
Clinical Immunology, 2009
View PDFchevron_right
Transient Down Modulation of CD20 by Rituximab in Patients with Chronic Lymphocytic Leukemia
sana naeem
2003
View PDFchevron_right
CD20 Antigen Density at Time of Presentation Is An Independent Predictor of Outcome in B-Cell Lymphoproliferative Disorders
Mohammad M Chisti
2008
View PDFchevron_right
Modulation of CD20 antigen expression after rituximab treatment: A retrospective study in patients with chronic lymphocytic leukemia
Oreste Villani
Clinical Therapeutics, 2010
View PDFchevron_right
Clinical Significance of Plasma Levels of Soluble CD 40 in Patients with Chronic Lymphocytic Leukemia
Liam Fernyhough
2013
View PDFchevron_right
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease
Maher Albitar
British Journal of Haematology, 2003
View PDFchevron_right
Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease
Marcin Pasiarski
Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2018
View PDFchevron_right
Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms
MOHAMED GHALLAB
International Journal of Hematology-Oncology and Stem Cell Research, 2020
View PDFchevron_right
Levels of expression of CD19 and CD20 in chronic B cell leukaemias
Ricardo Morilla
Journal of Clinical Pathology, 1998
View PDFchevron_right
Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells
Lukas Frenzel
British Journal of Haematology, 2011
View PDFchevron_right
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders
G. Pizzolo
International Journal of Clinical & Laboratory Research, 1995
View PDFchevron_right
Clinical significance of CD38 expression in chronic lymphocytic leukemia
Giovanni Capelli
…, 2001
View PDFchevron_right
Study of CD184 (CXCR4) Expression in Chronic Lymphocytic Leukemia Patients
Mostafa El- Razzaz
Egyptian Journal of Hematology and Bone Marrow Transplantation, 2018
View PDFchevron_right
CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow
Branimir Jaksic
Blood
View PDFchevron_right
The Role of CD200 in Differentiation Between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms in Sudanese Patients
Ali Osama
2019
View PDFchevron_right
Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia
G. Delespesse
Blood, 1996
View PDFchevron_right
CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression
Aryane cruz oliveira pinho
Frontiers in oncology, 2024
View PDFchevron_right
The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease
Rosario Giustolisi
Cancer, 2002
View PDFchevron_right
Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia
Mohamad Hussein
British Journal of Haematology, 2003
View PDFchevron_right
CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease
Peter THomas
2002
View PDFchevron_right
Application of anti-CD20 monoclonal antibodies in the treatment of lymphoproliferative diseases
Ivica Pejcic
Archive of Oncology, 2009
View PDFchevron_right
CD38 modifications in chronic lymphocytic leukemia: are they relevant?
G. Guida, Cristina Scielzo
Leukemia, 2004
View PDFchevron_right